NightstaRx's IPO

NightstaRx raised a round of funding on September 28, 2017. Investors include Public.

Nightstar is a private biopharmaceutical company focused on the development of therapies for retinal dystrophies. The Company's lead program is a retinal gene therapy for Choroideremia, a rare inherit…

Articles about NightstaRx's IPO: